About this trial
The goal of this study is to determine the effectiveness of a mobile exercise app in improving cardiovascular health and motivation to exercise in pregnant women who are healthy, in their 2nd trimester, between 18-45 years age, and do not do exercise currently. The aims of this study are determine i) the effect of a mobile app (BumptUp) to increase motivation to exercise as assessed by questionnaire, and ii) the changes may occur in cardiovascular health outcomes such as increased percent Flow-Mediated Dilation (FMD), Heart Rate Variability (HRV), and decreased Pulse Wave Velocity (PWV) over an 8-week period of intervention. Researchers will compare this to pregnant women who are healthy, in their 2nd trimester, between 18-45 years age, and who will not be using the mobile app (BumptUp) for exercise. Participants who are in the experimental group will be given access to the mobile app (BumptUp) for 8 weeks. Both the control and experimental group will visit the lab for their baseline measurements (study visit 1), followed by two visits at 4 weeks (study visit 2) and 8 weeks (study visit 3) to have their heart rate variability, arterial stiffness (PWV), and vascular function (FMD) assessed. At each study visit, blood pressure, heart rate, height, and weight will also be measured. Additionally, at all three study visits, participants will fill out a questionnaire to determine motivation to exercise.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age: 18-45 years.
Pregnant women who are 20-24 weeks pregnant at enrollment
Sedentary, as defined by completing less than 90 minutes of exercise each week.
Generally healthy, uncomplicated pregnancies.
Disqualifiers
Physician diagnosed cardiovascular/ vascular complications (heart disease, high blood pressure, Raynaud's phenomenon etc.)
Physician diagnosed metabolic diseases (diabetes, hypothyroidism)
Musculoskeletal injuries (broken bones, back pain, ankle sprain, muscle pull, etc.)
Medications that may impact blood vessel function such as hypertension medication (Angiotensin converting enzyme inhibitor, Angiotensin receptor blocker, Calcium channel blocker, beta blocker), lipid lowering agents (statins), Nitrates, steroids, etc.
Trial design
Parallel
Treatments tested in this trial
Experimental group using BumptUp mobile exercise app
BehavioralThis BumptUp app has been developed specifically for pregnancy with safety and screening feature. This intervention will be unique since the researchers will evaluate the cardiovascular health outcomes following the 8 weeks of intervention.
Treatment groups
Trial outcomes
Primary outcomes
Flow mediated dilation
The cardiovascular health via flow mediated dilation (% change from baseline) will be assessed
Secondary outcomes
Arterial stiffness
Cardiovascular health will be measured via arterial stiffness determining pulse wave velocity (m/sec)
Other outcomes
Heart rate variability
Cardiovascular health will be measured via heart rate variability (msec).
motivation to exercise
Motivation to exercise will be measured via questionnaire
Sponsors and contacts
Click on the lead sponsor to view all of their trials.